Wizz Air reports 15.5% passenger growth in December 2025

Wizz Air

Wizz Air Holdings Plc (LON:WIZZ) has reported strong December 2025 growth today and a range of important strategic developments during the month, which further strengthens its product-enhancing and regional densification strategies.

Wizz Air carried 5.85m million passengers in December, a 15.5% increase year-on-year, with capacity rising 16.3% to 6.81 million seats. The load factor for the month was 85.9%, down 0.6ppts year-over-year.

During the month:  

·      “4 to the power of 15”: Wizz Air’s network densification strategy saw four announcements in December in which a 15th aircraft will be added to the existing based fleets for the Summer ’26 season at Luton, Rome Fiumicino, Tirana and Warsaw-Chopin Airport.

·      Regional footprint further advanced: Wizz Air’s CEE footprint was expanded further with the official reopening of Targu Mures base in Romania (December 15th) with one aircraft and the opening of its Warsaw-Modlin base (December 1st) with two A321neos.

·      Distribution channels strengthened: On December 4th, Wizz Air announced its partnership with Kyte to open its 3rd party distribution platform to the corporate travel market. This follows the distribution agreement signed with Travelfusion in August, the world’s largest flight content aggregator.

·      NIS2 compliance: Wizz Air has demonstrated cyber resilience under the new EU NIS2 framework. In its inaugural pre-audit regarding these stringent regulations, the airline achieved a 97% score, securing the highest possible rating of ‘Compliant with Negligible Risk’.

   Month         Rolling 12 months    
   December2025   December2024   Change   YoY      December2025   December2024   Change   YoY   
Capacity (seats)   6,810,6035,853,738 16.3%    75,348,028 69,092,918 9.1% 
Passengers*   5,847,8285,061,425 15.5%    68,591,37162,686,711 9.4% 
Load Factor**   85.9% 86.5% -0.6ppts    91.0% 90.7% 0.3ppts 

*Booked passengers  

** Rounded to one decimal place

Wizz Air Monthly CO2 Emission Statistics*   

   Month         Rolling 12 months   
   December2025   December2024   Change   YoY      December2025   December2024   Change   YoY   
CO2 (MT)   Emissions   532,153482,95110.2%    6,024666 5,761,7324.6% 
CO2 g per pax/km**   52.353.7-2.5%    50.852.4 -3.2% 

* The published CO2 figures do not include any benefit from Wizz Air’s SAF uplift 

** Rounded to one decimal place

Share on:

Latest Company News

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

SIRT6 positions Genflow Biosciences in a high-value area of longevity research

Genflow Biosciences is targeting SIRT6 as a potential route to improve DNA repair, metabolic control and healthier ageing.

Biotech Growth Trust portfolio company AtaiBeckley to be acquired by Eli Lilly

Eli Lilly’s proposed acquisition of AtaiBeckley values the biotechnology company at up to $3.8 billion, including contingent milestone payments. The transaction is the latest in a series of portfolio acquisitions contributing to BIOG’s performance.

Bridgepoint reports record first-half results as EBITDA rises 78%

Bridgepoint reported higher first-half earnings, record capital returns to fund investors and continued fundraising progress towards its updated target.

Burberry Group reports first-quarter growth across all major product categories

Burberry Group Plc said first-quarter FY2027 comparable retail sales rose 5%, driven by strong performance in the Americas and Greater China and growth across women’s, men’s, accessories and children’s divisions. The luxury brand highlighted momentum in outerwear, scarves and e-commerce, along with rising new customer acquisition and improved wholesale guidance for the first half.

RM Plc Assessment Pipeline Doubles as RM Ava Opens New Growth Markets (video)

RM Plc CFO Simon Goodwin explains why the Assessment pipeline has doubled, how RM Ava could unlock new professional and government-regulated testing markets, and where further efficiencies will come from after £20 million of annualised savings.

    Search